510(k) K220558
K220558 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corporation for the device "Blood Administration Sets". The FDA issued a decision of Substantially Equivalent on November 17, 2022. The device falls under product code BRZ (Set, Blood Transfusion), a Class II device regulated under 21 CFR 880.5440. Baxter Healthcare Corporation has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 17, 2022
- Date Received
- February 28, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Set, Blood Transfusion
- Device Class
- Class II
- Regulation Number
- 880.5440
- Review Panel
- HO
- Submission Type